DK152670C - Analogifremgangsmaade til fremstilling af 1-(4-aryl-4-cyano-cyclohexyl)-4-aryl-4-piperidincarboxylsyre-derivater eller farmaceutisk acceptable syreadditionssalte og stereokemiske isomere deraf - Google Patents

Analogifremgangsmaade til fremstilling af 1-(4-aryl-4-cyano-cyclohexyl)-4-aryl-4-piperidincarboxylsyre-derivater eller farmaceutisk acceptable syreadditionssalte og stereokemiske isomere deraf

Info

Publication number
DK152670C
DK152670C DK029381A DK29381A DK152670C DK 152670 C DK152670 C DK 152670C DK 029381 A DK029381 A DK 029381A DK 29381 A DK29381 A DK 29381A DK 152670 C DK152670 C DK 152670C
Authority
DK
Denmark
Prior art keywords
aryl
stereochemists
analogue
cyclohexyl
cyano
Prior art date
Application number
DK029381A
Other languages
Danish (da)
English (en)
Other versions
DK29381A (da
DK152670B (da
Inventor
Raymond Stokbroekx
Marcel Luyckx
Joannes Willems
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of DK29381A publication Critical patent/DK29381A/da
Publication of DK152670B publication Critical patent/DK152670B/da
Application granted granted Critical
Publication of DK152670C publication Critical patent/DK152670C/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D211/62Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
    • C07D211/64Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4 having an aryl radical as the second substituent in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C29/00Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
    • C07C29/36Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring increasing the number of carbon atoms by reactions with formation of hydroxy groups, which may occur via intermediates being derivatives of hydroxy, e.g. O-metal
    • C07C29/38Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring increasing the number of carbon atoms by reactions with formation of hydroxy groups, which may occur via intermediates being derivatives of hydroxy, e.g. O-metal by reaction with aldehydes or ketones
    • C07C29/40Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring increasing the number of carbon atoms by reactions with formation of hydroxy groups, which may occur via intermediates being derivatives of hydroxy, e.g. O-metal by reaction with aldehydes or ketones with compounds containing carbon-to-metal bonds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/92Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with a hetero atom directly attached to the ring nitrogen atom
    • C07D211/96Sulfur atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/57Nitriles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK029381A 1980-01-24 1981-01-22 Analogifremgangsmaade til fremstilling af 1-(4-aryl-4-cyano-cyclohexyl)-4-aryl-4-piperidincarboxylsyre-derivater eller farmaceutisk acceptable syreadditionssalte og stereokemiske isomere deraf DK152670C (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US11492480A 1980-01-24 1980-01-24
US11492480 1980-01-24
US19163180 1980-09-29
US06/191,631 US4369184A (en) 1980-01-24 1980-09-29 1-(Cyclohexyl)-4-aryl-4-piperidinecarboxylic acid derivatives

Publications (3)

Publication Number Publication Date
DK29381A DK29381A (da) 1981-07-25
DK152670B DK152670B (da) 1988-04-11
DK152670C true DK152670C (da) 1988-08-22

Family

ID=26812674

Family Applications (1)

Application Number Title Priority Date Filing Date
DK029381A DK152670C (da) 1980-01-24 1981-01-22 Analogifremgangsmaade til fremstilling af 1-(4-aryl-4-cyano-cyclohexyl)-4-aryl-4-piperidincarboxylsyre-derivater eller farmaceutisk acceptable syreadditionssalte og stereokemiske isomere deraf

Country Status (25)

Country Link
US (1) US4369184A (el)
EP (1) EP0034415B1 (el)
AU (1) AU538130B2 (el)
BG (2) BG35465A3 (el)
CA (1) CA1187080A (el)
CS (1) CS221818B2 (el)
DE (1) DE3163787D1 (el)
DK (1) DK152670C (el)
ES (2) ES8204421A1 (el)
FI (1) FI76562C (el)
GR (1) GR71898B (el)
HK (1) HK81088A (el)
HU (1) HU183293B (el)
IE (1) IE50706B1 (el)
IL (1) IL61968A (el)
LU (1) LU88220I2 (el)
MA (1) MA19046A1 (el)
MY (1) MY8700593A (el)
NL (1) NL930017I2 (el)
NO (1) NO1994012I1 (el)
NZ (1) NZ196117A (el)
PH (1) PH16611A (el)
PL (2) PL127483B1 (el)
SU (1) SU1230467A3 (el)
YU (1) YU48446B (el)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6322584A (ja) * 1986-07-15 1988-01-30 Senjiyu Seiyaku Kk 1−ハイドロキシ−5−オキソ−5H−ピリド〔3,2−a〕フエノキサジン−3−カルボン酸エステル類
DE4108527A1 (de) * 1991-03-15 1992-09-17 Basf Ag Neue 1-(4-cyano-4-aryl-cyclohexyl)piperazine, ihre herstellung und verwendung
WO1995025518A1 (en) * 1994-03-18 1995-09-28 Ciba-Geigy Ag Aqueous solution of levocabastine for ophthalmic use
US5661163A (en) * 1995-06-07 1997-08-26 Merck & Co., Inc. Alpha-1a adrenergic receptor antagonists
DE69733664T3 (de) 1996-04-19 2011-04-14 Grifols Inc. (n.d. Ges.d.Staates Delaware), Los Angeles Verfahren zur INaktivierung von Viren und Lyophilisierung von Blutproteinen
US6267986B1 (en) 1999-09-24 2001-07-31 Ranbaxy Laboratories Limited Process for the preparation of a controlled drug delivery system containing pseudoephedrine and a long acting antihistamine
US20020146409A1 (en) * 2001-01-30 2002-10-10 Herring Steven W. Methods for stabilizing lyophilized blood proteins
WO2004019955A1 (en) 2002-08-30 2004-03-11 Altana Pharma Ag The use of the combination of ciclesonide and antihistamines for the treatment of allergic rhinitis
KR101294014B1 (ko) 2006-01-06 2013-08-09 선오비온 파마슈티컬스 인코포레이티드 모노아민 재흡수 저해제로서의 시클로알킬아민
WO2007143158A2 (en) 2006-06-01 2007-12-13 Schering-Plough Healthcare Products, Inc. Sustained release pharmaceutical formulation comprising phenylephrine
NZ573174A (en) 2006-06-01 2012-01-12 Msd Consumer Care Inc Sustained release pharmaceutical dosage form containing phenylephrine
US20090281156A1 (en) * 2007-12-21 2009-11-12 Schering-Plough Healthcare Products, Inc, Enhancing photostabilization of oxymetazoline
CN106831541B (zh) 2011-11-18 2019-09-06 赫普泰雅治疗有限公司 毒蕈碱性m1受体激动剂
GB201513743D0 (en) 2015-08-03 2015-09-16 Heptares Therapeutics Ltd Muscarinic agonists
US10259787B2 (en) 2016-10-14 2019-04-16 Heptares Therapeutics Limited Substituted cyclohexanes as muscarinic M1 receptor and/or M4 receptor agonists
GB201617454D0 (en) 2016-10-14 2016-11-30 Heptares Therapeutics Limited Pharmaceutical compounds
GB201810239D0 (en) 2018-06-22 2018-08-08 Heptares Therapeutics Ltd Pharmaceutical compounds
GB201819960D0 (en) 2018-12-07 2019-01-23 Heptares Therapeutics Ltd Pharmaceutical compounds
GB202020191D0 (en) 2020-12-18 2021-02-03 Heptares Therapeutics Ltd Pharmaceutical compounds

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1206436B (de) * 1957-07-05 1965-12-09 Janssen Pharmaceutica Nv Verfahren zur Herstellung von Derivaten von 2, 2-Diaryl-4-(4'-phenyl-piperidino)-butyronitrilen
NL127792C (el) * 1965-06-29

Also Published As

Publication number Publication date
YU48446B (sh) 1998-07-10
YU18381A (en) 1983-10-31
MY8700593A (en) 1987-12-31
FI76562B (fi) 1988-07-29
NO1994012I1 (no) 1994-08-30
PH16611A (en) 1983-11-24
DK29381A (da) 1981-07-25
ES498793A0 (es) 1982-05-01
PL229365A1 (el) 1982-03-29
DE3163787D1 (en) 1984-07-05
MA19046A1 (fr) 1981-10-01
AU538130B2 (en) 1984-08-02
PL127679B1 (en) 1983-11-30
IE810125L (en) 1981-07-24
NL930017I1 (nl) 1993-05-03
LU88220I2 (el) 1994-02-03
DK152670B (da) 1988-04-11
HU183293B (en) 1984-04-28
EP0034415B1 (en) 1984-05-30
PL233921A1 (el) 1982-06-21
US4369184A (en) 1983-01-18
NL930017I2 (nl) 1993-07-16
ES8204421A1 (es) 1982-05-01
GR71898B (el) 1983-08-11
FI76562C (fi) 1988-11-10
PL127483B1 (en) 1983-10-31
EP0034415A1 (en) 1981-08-26
BG60472B2 (bg) 1995-04-28
HK81088A (en) 1988-10-14
SU1230467A3 (ru) 1986-05-07
ES8307219A1 (es) 1983-07-01
ES508441A0 (es) 1983-07-01
CA1187080A (en) 1985-05-14
BG35465A3 (en) 1984-04-15
AU6625581A (en) 1981-07-30
NZ196117A (en) 1984-05-31
IL61968A0 (en) 1981-02-27
IL61968A (en) 1984-09-30
IE50706B1 (en) 1986-06-25
CS221818B2 (en) 1983-04-29
FI810193L (fi) 1981-07-25

Similar Documents

Publication Publication Date Title
DK152670C (da) Analogifremgangsmaade til fremstilling af 1-(4-aryl-4-cyano-cyclohexyl)-4-aryl-4-piperidincarboxylsyre-derivater eller farmaceutisk acceptable syreadditionssalte og stereokemiske isomere deraf
DK151623C (da) Analogifremgangsmaade til fremstilling af n-substituerede moranolinderivater eller farmaceutisk acceptable syreadditionssalte deraf
DK152430C (da) Analogifremgangsmaade til fremstilling af heterocyclisk substituerede 4-amino-6,7-dimethoxy-2-piperazinoquinazolin-derivater eller farmaceutisk acceptable syreadditionssalte deraf
DK161770C (da) Analogifremgangsmaade til fremstilling af cyklobutylaminderivater eller farmaceutisk acceptable salte deraf
DK74282A (da) Fremgangsmaade til fremstilling af imidazodiazepiner eller farmaceutisk acceptable syreadditionssalte deraf
DK160314C (da) Analogifremgangsmaade til fremstilling af bicycliske pyrimidin-5-on-derivater og farmaceutisk acceptable salte deraf
DK156720C (da) Analogifremgangsmaade til fremstilling af benzazepinderivater eller fysiologisk acceptable syreadditionssalte deraf
DK148711C (da) Analogifremgangsmaade til fremstilling af 1-(3-mercapto-2-methylpropanoyl)-prolyl-aminosyre-derivater, optiske isomere deraf eller farmaceutisk acceptable salte deraf
DK157860C (da) Analogifremgangsmaade til fremstilling af benzylimidazolderivater samt farmaceutisk acceptable syreadditionssalte deraf
DK445084A (da) 6-flour-1,4-dihydro-4-oxo-7-substituerede piperazinylquinolin-3-carboxylsyrederivater, fremgangsmaade til fremstilling af samme og farcaceutiske sammensaetninger indeholdende samme
DK162444C (da) Analogifremgangsmaade til fremstilling af azabicyklooctancarboxylsyrer og farmaceutisk acceptable salte heraf
DK166381C (da) Analogifremgangsmaade til fremstilling af (3-aminopropoxy)-bibenzylderivater og farmaceutisk acceptable salte deraf
DK157862C (da) Analogifremgangsmaade til fremstilling af imidazolylphenylamidiner eller farmaceutisk acceptable syreadditionssalte deraf
DK151017C (da) Analogifremgangsmaade til fremstilling af substituerede n-(4-indolyl-piperidino-alkyl)-benzimidazoloner eller fysiologisk acceptable syreadditionssalte deraf
DK161968C (da) Analogifremgangsmaade til fremstilling af imidazo-pyrazolo-pyrimidiner eller farmaceutisk acceptable salte deraf
NO810351L (no) G imidazolinderivater og fremgangsmaate til deres fremstillin
DK162842C (da) Analogifremgangsmaade til fremstilling af 1-perfluoralkyl-2-(1,2,4-triazol-1-yl)-ethanol-forbindelser eller farmaceutisk acceptable syreadditionssalte deraf
DK154557C (da) Analogifremgangsmaade til fremstilling af 3,4-dihydro-8-((2-hydroxy-3-alkylamino)-propoxy)-2h-1-benzopyranderivater eller et farmaceutisk acceptabelt syreadditionssalt deraf
DK148596C (da) Analogifremgangsmaade til fremstilling af 3-aminosubstituerede pyridaziner eller farmaceutisk acceptable syreadditionssalte deraf
DK154950C (da) Analogifremgangsmaade til fremstilling af 1-(benzazolylalkyl)-piperidinderivater eller de farmaceutisk acceptable syreadditionssalte deraf
DK154647C (da) Analogifremgangsmaade til fremstilling af n-oe(4-oe3-substitueret 2-pyridylaapiperazino)butylaaazaspirodecanforbindelser eller et farmaceutisk acceptabelt syreadditionssalt deraf
DK161699C (da) Analogifremgangsmaade til fremstilling af 4-aryl-4-piperidincarbinoler eller farmaceutisk acceptable salte deraf
DK149077C (da) Analogifremgangsmaade til fremstilling af encephalin-analoge pentapeptidamidderivater eller farmaceutisk acceptable syreadditionssalte deraf
DK160498C (da) Analogifremgangsmaade til fremstilling af 3-methyl-flavon-8-carboxylsyreestere eller farmaceutisk acceptable syreadditionssalte deraf
DK157023C (da) Analogifremgangsmaade til fremstilling af imidazodiazepiner eller farmaceutisk acceptable syreadditionssalte deraf

Legal Events

Date Code Title Description
CTFF Application for supplementary protection certificate (spc) filed

Free format text: CA 1993 00010, 930205

CTFF Application for supplementary protection certificate (spc) filed

Free format text: CA 1993 00010, 930205

PUP Patent expired